TOPLINE: Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations. METHODOLOGY: Researchers conducted a retrospective review of 241 patients (82.6% women; mean age, 58.4 years; 49.8% White; 14.1% Black) diagnosed with lymphocytic scarring alopecia between 2009 and 2023 to ...
.png)
55W 14th St Ste 101, Helena, MT, 59601 US
+1 (406) 319 1601
news.in.usa@olahost.top
Copyright © 2024 olahealth. All Rights Reserved
